Pancreatic safety of GLP-1-based therapeutic agents: further insights from rodent studies? Jens Juul Holst Commentary 03 July 2013 Pages: 1869 - 1872
Who was first to diagnose and report neuropathic arthropathy of the foot and ankle: Jean-Martin Charcot or Herbert William Page? Lee J. SandersMichael E. EdmondsWilliam J. Jeffcoate Commentary 14 June 2013 Pages: 1873 - 1877
Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation? M. A. NauckO. BaranovJ. J. Meier For Debate 08 June 2013 Pages: 1878 - 1883
Setting the record straight on TIDE: a lost opportunity for patients with diabetes Zubin PunthakeeJackie BoschHertzel C. Gerstein For Debate 06 June 2013 Pages: 1884 - 1887
The prenatal environment and type 1 diabetes L. C. SteneE. A. M. Gale Review 10 May 2013 Pages: 1888 - 1897
Molecular mechanism of action of metformin: old or new insights? Graham RenaEwan R. PearsonKei Sakamoto Review Open access 09 July 2013 Pages: 1898 - 1906
The association of the mitochondrial DNA OriB variant (16184–16193 polycytosine tract) with type 2 diabetes in Europid populations Zheng YeChristopher GillsonNicholas J. Wareham Meta-analysis Open access 24 May 2013 Pages: 1907 - 1913
Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial Andrei KeidarKaren J. HershkopRam Weiss Short Communication 14 June 2013 Pages: 1914 - 1918
The use of intermediate endpoints in the design of type 1 diabetes prevention trials Jeffrey P. Krischerthe Type 1 Diabetes TrialNet Study Group Article 07 June 2013 Pages: 1919 - 1924
UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82 A. J. HayesJ. LealP. M. Clarke Article 22 June 2013 Pages: 1925 - 1933
Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy S. WheelerK. MooreE. J. Boyko Article 25 June 2013 Pages: 1934 - 1943
Cancer detection rates following enrolment in a disease management programme for type 2 diabetes A. S. GeierJ. WellmannH. W. Hense Short Communication 31 May 2013 Pages: 1944 - 1948
Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition M. A. SchroijenM. W. M. van de LuijtgaardenO. M. Dekkers Article 15 June 2013 Pages: 1949 - 1957
Improved genetic testing for monogenic diabetes using targeted next-generation sequencing S. EllardH. Lango AllenR. Caswell Short Communication Open access 15 June 2013 Pages: 1958 - 1963
In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions E. MbunweB. J. Van der AuweraThe Belgian Diabetes Registry Article 28 May 2013 Pages: 1964 - 1970
Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α A. MeersonM. TraurigL. J. Baier Article Open access 12 June 2013 Pages: 1971 - 1979
Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice J. H. EllenbroekH. A. M. TönsE. J. P. de Koning Article 16 June 2013 Pages: 1980 - 1986
Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice Jennifer E. BruinAlireza RezaniaTimothy J. Kieffer Article 16 June 2013 Pages: 1987 - 1998
Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function Chen WangXiaowen LiWeiping Jia Article 22 June 2013 Pages: 1999 - 2009
The loss of Sirt1 in mouse pancreatic beta cells impairs insulin secretion by disrupting glucose sensing L. LuuF. F. DaiM. B. Wheeler Article 20 June 2013 Pages: 2010 - 2020
A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid S. ForbesI. F. GodslandD. G. Johnston Article 13 June 2013 Pages: 2021 - 2033
Acute reduction of lipolysis reduces adiponectin and IL-18: evidence from an intervention study with acipimox and insulin B. LindegaardS. DitlevsenB. K. Pedersen Article Open access 29 June 2013 Pages: 2034 - 2043
LXR is a negative regulator of glucose uptake in human adipocytes A. M. L. PetterssonB. M. StensonJ. Laurencikiene Article 15 June 2013 Pages: 2044 - 2054
Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action S. A. ParanjapeO. ChanR. S. Sherwin Short Communication 20 June 2013 Pages: 2055 - 2058
Hepatic DNA methylation modifications in early development of rats resulting from perinatal BPA exposure contribute to insulin resistance in adulthood Y. MaW. XiaS. Q. Xu Article 08 June 2013 Pages: 2059 - 2067
Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy T. H. GuanG. ChenJ. C. Krepinsky Article 21 June 2013 Pages: 2068 - 2077
Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: a potential link between dietary fat composition and the pathophysiological outcomes of obesity T. GengW. HuL. A. Cowart Article 03 July 2013 Pages: 2078 - 2087
Continuous hypothalamic KATP activation blunts glucose counter-regulation in vivo in rats and suppresses KATP conductance in vitro Craig BeallElizabeth HaythorneRory J. McCrimmon Short Communication 22 June 2013 Pages: 2088 - 2092
DNA methylation in monozygotic quadruplets affected by type 1 diabetes Giulio DisantoJana VcelakovaKateřina Štechová Research Letter 23 June 2013 Pages: 2093 - 2095
Secondary analysis of electronic databases: potentials and limitations S. AsghariM. Mahdavian Letter 28 June 2013 Pages: 2096 - 2097
Secondary analysis of electronic databases: potentials and limitations. Reply to Asghari S, Mahdavian M [letter] K. KostevW. Rathmann Letter 11 July 2013 Pages: 2098 - 2099
The vitamin K-dependent Gla proteins and risk of type 2 diabetes R. L. KennedyV. VangavetiD. McCulloch Letter 13 June 2013 Pages: 2100 - 2101
RETRACTED ARTICLE: Common variation in PPARGC1A/B and progression to diabetes or change in metabolic traits following preventive interventions: the Diabetes Prevention Program P. W. FranksC. A. Christophion behalf of the Diabetes Prevention Program Research Group Retraction Note 25 April 2013 Pages: 2102 - 2102
Erratum to: Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3 E. LawS. LuL. Marzban Erratum 06 July 2013 Pages: 2103 - 2104
Erratum to: Intensive glucose control and risk of cancer in patients with type 2 diabetes G. StefansdottirS. ZoungasM. L. De Bruin Erratum 28 June 2013 Pages: 2105 - 2106